Technical Analysis for MITO - Stealth BioTherapeutics Corp.

Grade Last Price % Change Price Change
grade D 11.75 -2.08% -0.25
MITO closed down 2.08 percent on Monday, March 25, 2019, on 74 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A N/A Down
See historical MITO trend table...

Date Alert Name Type % Chg
Mar 25 New 52 Week Closing Low Bearish 0.00%
Mar 25 New Downtrend Bearish 0.00%
Mar 25 Hot IPO Pullback Bullish Swing Setup 0.00%
Mar 25 Inside Day Range Contraction 0.00%
Mar 25 Wide Bands Range Expansion 0.00%
Mar 25 Down 3 Days in a Row Weakness 0.00%
Mar 25 Down 4 Days in a Row Weakness 0.00%
Mar 25 Down 5 Days in a Row Weakness 0.00%
Mar 25 Oversold Stochastic Weakness 0.00%
Mar 22 Hot IPO Pullback Bullish Swing Setup -2.08%

Older signals for MITO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate, Elamipretide, has the potential to treat rare genetic and common age-related mitochondrial diseases. The company's product candidates include SBT-20, a small peptide that targets and binds reversibly to cardiolipin, stabilizing mitochondrial structure, and function under conditions of oxidative stress; and SBT-272, a lead discovery pipeline compound, evaluating for rare neurodegenerative diseases, such as amyotrophic lateral sclerosis. Stealth BioTherapeutics Corp was founded in 2006 and is based in Newton, Massachusetts.
Biotechnology Biology Diseases Amyotrophic Lateral Sclerosis Peptides Senescence Degenerative Disease Neurodegeneration Mitochondrion
Is MITO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.8
52 Week Low 11.11
Average Volume 28,607
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 13.821
10-Day Moving Average 13.5952
Average True Range 1.2533
ADX 30.0
+DI 20.7783
-DI 24.6201
Chandelier Exit (Long, 3 ATRs ) 17.0401
Chandelier Exit (Short, 3 ATRs ) 15.0669
Upper Bollinger Band 17.2297
Lower Bollinger Band 10.4123
Percent B (%b) 0.2
BandWidth 49.326387
MACD Line 0.0135
MACD Signal Line 0.4631
MACD Histogram -0.4496
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.85
Resistance 3 (R3) 12.97 12.72 12.66
Resistance 2 (R2) 12.72 12.44 12.66 12.60
Resistance 1 (R1) 12.24 12.27 12.12 12.12 12.54
Pivot Point 11.99 11.99 11.93 11.93 11.99
Support 1 (S1) 11.51 11.71 11.39 11.39 10.96
Support 2 (S2) 11.26 11.54 11.20 10.90
Support 3 (S3) 10.78 11.26 10.84
Support 4 (S4) 10.66